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INTRODUCTION D ryeyecanbeapre-angiogenicandpre-inflammatory milieu [1] [2] [3] [4] [5] [6] .Therefore,preoperativecornealdryness aggravates injury or surgery-inducedneovascularization (NV),lymphangioggenesis(LY)andinflammation. Inpatientswithdryeye,preoperativesuppressionof inflammationisconsideredtobeimportantforfosteringa lessinflammatorymilieubeforesurgery [4, [7] [8] [9] [10] . Accordingly,postoperativesuppressionofinflammationis moreimportantinpatientswithdryeyecomparedwith patientswithoutdryeye,becausedryeyecorneasexhibit amplifiedinflammationandpreangiogeniccharacteristics aftersurgery. Manyresearchers [11] [12] haveshownthatthecoremechanismof dryeyediseaseisinflammation.Thetreatmentwithtopical orsystemicanti-inflammatorydrugsimprovesdryeye diseasesymptomandsigns [12] [13] [14] [15] . Theinflammatoryroleisincreasedaccordingtotheseverity ofdryeye [13] [14] [15] .Wehypothesizedthattheremaybeagreater roleofanti-vascularendothelialgrowthfactor-A(VEGF-A) therapyespeciallyinseveredryeyewithinflammation,such aspreexistingdryeyewithocularsurgery. Eventhoughtheeffectofbevacizumabfortreatingocular surfaceinflammationanddryeyehasbeenreported [16] [17] [18] ,there hasnotbeenanyfurtherresearchontheroleofotheranti-VEGF-AagentsindryeyediseasewithinflammatoryNV. Here,weevaluatedtheeffectoftrappingVEGF-A, afliberceptasatreatment. WeevaluatedwhethertrappingVEGF-Acouldsuppress postoperativeangiogenesisandinflammationindryeyesand wecomparedtheeffectswiththoseachievedinnon-dryeyes. Wealsoevaluatedwhethertheeffectiscomparabletothatof wellknownanti-inflammatorytreatment,corticosteroids.
MATERIALSANDMETHODS ExperimentAnimalModel Micewereassignedtooneof2
groups,thenormaleye(non-dryeye,38eyes)orthe anticholinergic-inducedexperimentaldryeyemodel(42 eyes).Inthedryeyegroup,webegandryeyeinduction2wk beforetheplannedsurgicalinsults.Dryeyewasinducedin themicebypharmacologicallyapplyingatopicalapplication of1%atropinesulfate(AlconKorea,Seoul,SouthKorea) twiceinthefirst48hoftheexperiment [19] .Subcutaneous injectionsof0.3mLof10mg/mLscopolaminehydrobromide (Sigma-Aldrich,St.Louis,MO,USA)werealsogiven2 timesadayeachdayfortheentiredurationoftheexperiment (23d) [19] . ,mouseVEGF-A [20] ,mouseTNF-alpha [21] , andmouseIL-6 [22] . [3, [11] [12] 15, 23] . Dryocularsurfacespresentvariabledegreesofinflammation characterizedbyanenhancedexpressionofproinflammatory cytokines;chemokinessuchasIL-6andTNF-alpha;and immunecellssuchaslymphocytes,macrophages,and dendriticcells [15, 24] .Inseveredryeyedisease,therewouldbe agreaterinflammatoryrole.The concentrationof inflammatorycytokinesand chemokinesisincreased accordingtotheseverityofdryeye [13] [14] [15] . Thestatusofcorneasofpre-existingdryeyecanhavehigher potentialforpostoperativecomplication [4, 8, 10] .Inthesestatusof severedryeyewithinflammatoryNVafterocularsurgery, wecanexpectthattheremaybearoleofanti-VEGF-A therapy.
Inourpreviousreports,postoperativecornealinflammation andlymph(angiognenesis)weresignificantlyincreasedindry corneascomparedwithnon-drycorneas [4] .Thus,dryeyecan bepartofapre-angiogenicmilieuthatcanswitch immediatelyintoamplifiedangiogenesiswithonlyminimal additionalcornealinjury. Basedontheinflammatorypathogenesisofdryeye disease [11] [12] ,delayindryeyediseaseprogressionmaybe achievedbyanymeansthatcanbreaktheviciouscycleof ocularsurfaceinflammation.Indeed,severalreportshave alreadyrevealedthattreatmentwithtopicalorsystemic anti-inflammatorydrugs,suchascyclosporineandsteroids, improvesdryeyediseasesymptomandsigns [12, 15] . Alongwithinflammation,dryeyediseasehasincreasingly beenrelatedtopathologic(lymph)angiogenesis [1] [2] 15, 25] . Moreover,surgicalinsultsonocularsurfacecanaggrevate dryeye [4, [7] [8] [9] 26] . Ourreal-timepolymerasechainreactionanalysisofgene expressionlevelsinunoperatedcorneasshowedthat VEGF-A,TNF-alpha,andIL-6wereexpressedathigher levelsindrycorneasthaninnon-drycorneas.Similarly, Goyal [1] [2] reportedincreasedVEGF-A,VEGF-C,and VEGF-Dlevelsindrycorneas.Drycorneashavelostocular surfacehomeostasis,whichalsoincludestheangiogenic privilegeofcornea,meaningthatthenormaltransparent corneaisdevoidoflymphaticandbloodvessels [24, 27] . Distruptionofthenormalimmunoregulatorymechanismin dryeyediseasecanleadtoinflammationandpathologic (lymph)angiognesis. Thusweproposethatanti-(lymph)angiogenicagentsarea potentialtherapeuticoptionfordryeyecorneasaftersurgical insults. VEGF-Cblockagehasalreadybeenreportedtohaveantilymphangiogneniceffectsindryeyes [2] .Lymphangiogenesis indryeyecorneaswassignificantlydecreasedbyblocking VEGF-C. However,fewstudieshaveinvestigatedtheeffectoftrapping VEGF-Aindryeye.Jiang [16] andErdurmusand Totan [17] reportedtheeffectofbevacizumabfortreating ocularsurfaceinflammationindryeye. WehypothesizedthatVEGF-Atrappingisaneffective treatmentfordryeyebecauseincreasingevidenceindicates thatdryeyeisrelatedtolymph(angiogenesis),especiallywith onlyminimaladditionalcornealinjury [1] [2] [24] [25] .Herewetested theeffectofVEGF-Atrappingindryeyecorneaand comparedtheeffectsofVEGF-Atrappingindry non-dry eyecorneasaftersurgicalinsult. Wealsoaddedacornealsuturemodeltothedryeyemodel toamplifyNVandinflammation.Theseadditionsenabledus tobettertestwhetherVEGF-AtrappingcandecreaseNVand inflammationasatreatmentofdryeye. InflammationandNVafterocularsurgeryarebothmediated byVEGF-A [27] [28] . CornealangiogenesisisdrivenbyVEGF-Aandplaysan importantpathogenicroleinavarietyofocularsurface diseases.AngiogenicresponsestoVEGF-Aaremediatedby VEGFreceptor1(Flt-1)andVEGFR-2(KDR) [28] .Inaddition toangiogenesis,vascularendothelialgrowthfactorreceptor-1 (VEGFR-1)isinvolvedinVEGF-dependentmigrationand gene expressionofmonocytesandmacrophages [28] [29] [30] .
VEGF-A,whichacts
VEGFreceptor2,isthoughttobe themainstimulator ofangiogenesisandvascular permeabilityinneovasculardisease [20] .Thusblockingthe VEGF-VEGFreceptoraxiscanreduce bothNVand inflammation [17] [18] . Inflammationindryeyehasclassicallybeentreatedwith steroidsandcyclosporine [12] . Corticosteroidtherapyhasbeenthestandard anti-inflammatoryandanti-angiogenictreatmentfordiseases associated with cornealNVandinflammation [31] [32] [33] . [31] [32] [33] . Inourmodelofinduceddryeyecorneasandocularsurface surgery,weusedaflibercepttotrapVEGF-A.Aflibercepthas beenwidelyusedtotrapVEGF-Aasananti-angiogenic treatment.Afliberceptisafusionprotein,combiningthekey bindingdomainsofVEGFreceptors1and2andtheFc portionofimmunoglobulinG [34] [35] [36] .Afliberceptbinds VEGF-Awithhigher affinitythanbevacizumaband ranibizumab [35, 37] .ItalsobindsVEGF-BandPLGF [37] . AfliberceptbindsandneutralizesallisoformsofVEGF-A, butdoesnotdirectlyblockVEGF-CorD [35, 37] . Wefoundthattheanti-angiogenicandanti-inflammatory effectsoftrappingVEGF-Aweresignificantlyeffectivefor treatingdryeyecorneaswithcornealsurgery.However,this strategydidnothaveanysignificanteffectsinnon-dryeyes. Wesuggestthisdifferenceisduetothepreangiogenicmilieu inthedryeye.Specifically,VEGF-Aandcytokinesare expressedathigherlevelsinpostoperativedryeyecorneas, whicharethenmoresusceptibletoanti-angiogenicand anti-inflammatorytreatments. Dryeyecorneashavehigherlevelsofangiogenesisand inflammationandalsohaveheightenedresponsesto anti-angiogenicandanti-inflammatoryagents. OurimmunohistochemicalstainingofCD31andCD11b revealedthattrappingVEGF-Awasmoreeffectivein decreasingNVandinflammationthandexamethasoneinboth dryandnon-dryeyecorneas. Inaslightlydifferentapproach,Nakao [38] comparedthe effectsofdexamethasoneandbevacizumabandfoundthat dexamethasonehadalargertherapeuticwindowin inflammatoryangiogenesis.Moreover,Mirabelli [39] reportedthatdexamethasonehadasuperioreffectto anti-VEGF-Ainreducinginflammatoryangiogenesis. Dexamethasoneisaclassictreatmentofdryeyeandis knowntopartlyact anti-VEGF-A [32] . However,wefoundthattheVEGFtrapwassuperiorto dexamethasoneasananti-inflammatoryagentandasan anti-angiogenesisagent,irrespectiveofthedrynessofthe cornea.WehypothesizethattheVEGFtrapafliberceptisa strongeranti-angiogenicandanti-inflammatoryagentandhas awiderspectrumthantheseotheranti-VEGFagents [25, 37, 40] . Althoughanti-VEGFagentsappeartohavebeneficialeffects, theyhavealsobeenreportedtohavesomesideeffects [41] [42] . Specialcareshouldbetakentouseanti-VEGFagentson damagedcorneassuchasthosefoundindryeyeandocular surfaceinjury,sinceanti-VEGFagentscaninhibitwound healing. Weshouldalsoconsidertheindicationofuseoftrapping VEGF-A.Asseeninourresults,theanti-angiogenicand anti-inflammatoryeffectsoftrappingVEGF-Awere significantlyeffectivefortreatingdryeyecorneaswith cornealsurgery,howevernosignificanteffectsinnon-dry eyes.Theroleofanti-VEGFmightbegreaterinseveredry eyewithocularsurfaceinflammation. Ourresultsindicatethattheanti-angiogenicaswellas anti-inflammatoryeffectsofVEGF-Atrappingmakeita potentialtherapeuticoptionfordryeyecorneasaftersurgical insults.
